Related Experiment Video
Updated: Jun 13, 2026

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
Methylphenidate effect in children with ADHD can be measured by an ecologically valid continuous performance test
Yehuda Pollak1, Hanan Barhoum Shomaly, Patrice L Weiss
1Shaare Zedek Medical Center, Jerusalem, Israel. msyehu@huji.ac.il
The virtual reality continuous performance task (VR-CPT) effectively measures methylphenidate (MPH) response in children with attention-deficit/hyperactivity disorder (ADHD). This engaging VR-CPT shows greater sensitivity in detecting MPH
Area of Science:
- Neuroscience
- Psychology
- Pediatrics
Background:
- Virtual reality continuous performance tasks (VR-CPTs) are sensitive tools for detecting cognitive deficits in attention-deficit/hyperactivity disorder (ADHD).
- Methylphenidate (MPH) is a common treatment for ADHD, and its effectiveness needs reliable assessment methods.
Purpose of the Study:
- To compare the performance of children with ADHD on a VR-CPT with and without methylphenidate (MPH) treatment.
- To evaluate the VR-CPT's efficacy against a standard CPT, the Test of Variables of Attention (TOVA).
Main Methods:
- Twenty-seven children with ADHD participated in a double-blind, placebo-controlled, crossover study.
- Participants completed VR-CPT, a non-VR CPT, and TOVA after receiving either MPH or a placebo.
- Subjective experiences with the tasks were recorded using the Short Feedback Questionnaire.
Main Results:
- MPH significantly reduced omission errors more effectively on the VR-CPT than on the no VR-CPT or TOVA.
- MPH demonstrated a similar degree of improvement across other CPT measures for all task types.
- Children found the VR-CPT to be more enjoyable than the other CPT formats.
Conclusions:
- The VR-CPT is a sensitive and user-friendly tool for assessing MPH response in children with ADHD.
- The VR-CPT's engaging nature may enhance compliance and data quality in cognitive assessments for ADHD.
More Related Videos
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...